Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy

McDonald, T. J., Driedger, A. A., Garcia, B. M., Uum, S. H. M. V., Rachinsky, I., Chevendra, V., Breadner, D., Feinn, R., Walsh, S. J., & Malchoff, C. D. (2011). Familial Papillary Thyroid Carcinoma: A Retrospective Analysis. Journal of Oncology, 2011(), 82-89. https://doi.org/10.1155/2011/948786
Parenti, R., Salvatorelli, L., & Magro, G. (2014). Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71. International Journal of Endocrinology, 2014(), 485-495-154. https://doi.org/10.1155/2014/685396
Blesa, J. M. G., Pulido, E. G., Pulla, M. P., Candel, V. A., Canales, J. B. L., Arrom, M. G., & Rico, P. M. (2010). Old and New Insights in the Treatment of Thyroid Carcinoma. Journal of Thyroid Research, 2010(), 20-35. https://doi.org/10.4061/2010/279468
Saeed, M. F., Sakrani, N. F., Juma, I. M., & Ali, A. (2017). Medullary thyroid carcinoma: Management and complexities of postoperative follow-up. International Journal of Case Reports and Images (IJCRI), 8(3), a1+171-174. https://doi.org/10.5348/ijcri-201728-CR-10767
Pinchot, S. N., Kunnimalaiyaan, M., Sippel, R. S., & Chen, H. (2009). Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions. Journal of Oncology, 2009(), 128-134. https://doi.org/10.1155/2009/183031